Subtopic Deep Dive
Preeclampsia Risk Factors
Research Guide
What is Preeclampsia Risk Factors?
Preeclampsia risk factors are epidemiological, genetic, and environmental variables identified through cohort studies and meta-analyses that predict the onset of preeclampsia in pregnancy.
Key factors include prior preeclampsia history, obesity, diabetes, and angiogenic imbalances like elevated sFlt-1 and reduced PlGF (Levine et al., 2004; 3512 citations). Systematic reviews quantify risks at antenatal booking (Duckitt and Harrington, 2005; 1770 citations). Over 10 major papers from 2003-2019 analyze these associations, with Maynard et al. (2003; 3888 citations) linking placental sFlt1 to endothelial dysfunction.
Why It Matters
Identifying risk factors like high-risk history enables low-dose aspirin prophylaxis, reducing preterm preeclampsia incidence (Rolnik et al., 2017; 2069 citations). Modifiable factors such as obesity inform public health interventions, potentially preventing 20% of cases through personalized screening. Long-term, preeclampsia history elevates cardiovascular risk, guiding postpartum care (Bellamy et al., 2007; 2474 citations).
Key Research Challenges
Heterogeneity in Risk Factor Effects
Cohort studies show varying odds ratios for factors like obesity across populations (Duckitt and Harrington, 2005). Meta-analyses struggle with study design differences, complicating pooled estimates. Gene-environment interactions remain understudied.
Developing Accurate Prediction Models
Integrating angiogenic markers like sFlt-1/PlGF ratios with clinical risks yields predictive models (Levine et al., 2004). Validation across diverse ethnicities is limited. Balancing sensitivity and specificity challenges clinical adoption.
Distinguishing Causality from Association
Observational data links diabetes to preeclampsia but causal pathways are unclear (Metzger et al., 2010). Angiogenic factors associate with disease but intervention trials are sparse. Confounders like chronic hypertension obscure true risks.
Essential Papers
International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
Unknown, Boyd E Metzger, Steven G Gabbe et al. · 2010 · Diabetes Care · 5.2K citations
In the accompanying comment letter (1), Weinert summarizes published data from the Brazilian Gestational Diabetes Study (2) and comments on applying International Association of Diabetes and Pregna...
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia
Sharon E. Maynard, Jiang-Yong Min, Jaime R. Merchan et al. · 2003 · Journal of Clinical Investigation · 3.9K citations
Preeclampsia, a syndrome affecting 5% of pregnancies, causes substantial maternal and fetal morbidity and mortality. The pathophysiology of preeclampsia remains largely unknown. It has been hypothe...
Circulating Angiogenic Factors and the Risk of Preeclampsia
Richard J. Levine, Sharon E. Maynard, Cong Qian et al. · 2004 · New England Journal of Medicine · 3.5K citations
Increased levels of sFlt-1 and reduced levels of PlGF predict the subsequent development of preeclampsia.
Circulating angiogenic factors and the risk of preeclampsia*
· 2004 · Obstetrics and Gynecology · 2.6K citations
The following abstracts of articles from leading journals have been selected on the basis of their importance to the practice of obstetrics and gynecology.
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
Leanne Bellamy, Juan-Pablo Casas, Aroon D. Hingorani et al. · 2007 · BMJ · 2.5K citations
A history of pre-eclampsia should be considered when evaluating risk of cardiovascular disease in women. This association might reflect a common cause for pre-eclampsia and cardiovascular disease, ...
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik, D. Wright, Liona C. Poon et al. · 2017 · New England Journal of Medicine · 2.1K citations
Treatment with low-dose aspirin in women at high risk for preterm preeclampsia resulted in a lower incidence of this diagnosis than placebo. (Funded by the European Union Seventh Framework Program ...
Evaluation of High-Sensitivity C-Reactive Protein and Serum Lipid Profile in Southeastern Nigerian Women with Pre-Eclampsia
Anaelechi J. Onuegbu, Japhet M. Olisekodiaka, John U. Udo et al. · 2015 · Medical Principles and Practice · 2.0K citations
<b><i>Objective:</i></b> To evaluate the serum C-reactive protein (CRP) and lipid profile in women with pre-eclampsia. <b><i>Materials and Methods:</i><...
Reading Guide
Foundational Papers
Start with Duckitt and Harrington (2005) for systematic risk quantification at booking; Maynard et al. (2003) for sFlt1 pathophysiology; Levine et al. (2004) for angiogenic predictors—these establish core associations cited >9000 times total.
Recent Advances
Rolnik et al. (2017) for aspirin RCT in high-risk pregnancies; Rana et al. (2019) for updated pathophysiology integrating risks.
Core Methods
Meta-analyses of controlled studies (Duckitt 2005); prospective cohorts with biomarker assays (Levine 2004, 2006); logistic regression for prediction models (Rolnik 2017).
How PapersFlow Helps You Research Preeclampsia Risk Factors
Discover & Search
Research Agent uses searchPapers and citationGraph to map Duckitt and Harrington (2005) as a hub for 1770-cited risk factor meta-analysis, revealing clusters around Levine et al. (2004) and Maynard et al. (2003). exaSearch uncovers hidden cohort studies on obesity risks; findSimilarPapers extends to 50+ related papers.
Analyze & Verify
Analysis Agent applies readPaperContent to extract odds ratios from Duckitt and Harrington (2005), then runPythonAnalysis with pandas to meta-analyze risk ratios across 10 papers. verifyResponse via CoVe checks claims against GRADE evidence grading, verifying high-quality cohorts like Rolnik et al. (2017).
Synthesize & Write
Synthesis Agent detects gaps in gene-environment studies via contradiction flagging between Bellamy et al. (2007) and recent works. Writing Agent uses latexEditText, latexSyncCitations for risk model reviews, and latexCompile to generate publication-ready tables; exportMermaid diagrams angiogenic pathways.
Use Cases
"Meta-analyze odds ratios for obesity as preeclampsia risk from top cohort studies."
Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of ORs from Duckitt 2005, Levine 2004) → CSV export of pooled estimates with confidence intervals.
"Draft a review section on angiogenic risk factors with citations and figure."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Levine 2004, Maynard 2003) → latexCompile → exportMermaid for sFlt-1/PlGF pathway diagram.
"Find code for preeclampsia risk prediction models from papers."
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis sandbox test of model on sample cohort data.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers → citationGraph on Duckitt 2005 → readPaperContent 50+ papers → GRADE grading → structured report on risk factors. DeepScan applies 7-step analysis with CoVe checkpoints to verify aspirin efficacy from Rolnik 2017. Theorizer generates hypotheses on sFlt-1 causality from Maynard 2003 clusters.
Frequently Asked Questions
What defines preeclampsia risk factors?
Epidemiological variables like prior history, obesity, and nulliparity quantified by odds ratios in meta-analyses (Duckitt and Harrington, 2005).
What are key methods for studying these factors?
Cohort studies measure angiogenic imbalances (sFlt-1/PlGF; Levine et al., 2004); meta-analyses pool booking risks (Duckitt and Harrington, 2005); RCTs test interventions like aspirin (Rolnik et al., 2017).
What are the most cited papers?
Maynard et al. (2003; 3888 citations) on sFlt1; Levine et al. (2004; 3512 citations) on angiogenic prediction; Duckitt and Harrington (2005; 1770 citations) on antenatal risks.
What open problems exist?
Causal pathways for gene-environment interactions; ethnic-specific prediction models; long-term cardiovascular risk stratification post-preeclampsia (Bellamy et al., 2007).
Research Pregnancy and preeclampsia studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Preeclampsia Risk Factors with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers